MAXALT

This brand name is authorized in Austria, Australia, Brazil, Canada, Germany, Estonia, Spain, Finland, France, Croatia, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug MAXALT contains one active pharmaceutical ingredient (API):

1 Rizatriptan UNII WR978S7QHH - RIZATRIPTAN BENZOATE

Rizatriptan binds selectively with high affinity to human 5-HT1B and 5-HT1D receptors. The therapeutic activity of rizatriptan in treating migraine headache may be attributed to its agonist effects at 5-HT1B and 5-HT1D receptors on the extracerebral intracranial blood vessels that are thought to become dilated during an attack and on the trigeminal sensory nerves that innervate them. Read about Rizatriptan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MAXALT Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02CC04	Rizatriptan	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 9313E
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525501401110219
Country: CA	Health Products and Food Branch	Identifier(s): 02240518, 02240519, 02240521
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00074435, 00074530, 00074547, 01018143, 01018166, 02404262, 02404374, 16835907
Country: EE	Ravimiamet	Identifier(s): 1032804, 1076981, 1503919, 1503920, 1503931, 1503942, 1503964, 1503975, 1503986, 1503997, 1504000, 1504011, 1504022, 1504033, 1504044, 1504055, 1504066, 1504077, 1504088, 1504099, 1807208, 1853704, 1866584, 1866595
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 034115117, 10-8012, 3400934794407, 62289, 62291
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 396051, 397604, 398222, 539452
Country: FR	Base de données publique des médicaments	Identifier(s): 64983766, 69922564
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139294, 144849, 19131, 19154, 19155, 196163, 196962, 199686, 199688, 199691, 204127, 32051, 32053, 373622, 373623, 373642, 373643, 376750, 381485
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-455098518
Country: IT	Agenzia del Farmaco	Identifier(s): 034115042, 034115055, 034115105, 034115117
Country: JP	医薬品医療機器総合機構	Identifier(s): 2160006F1026, 2160006F2022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003815, 1014092, 1062313, 1062314, 1062315, 1089052, 1089053, 1090880, 1090881
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 024M98
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 50504, 50520
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100252922, 100253063, 100253070, 100253152
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68314001, W68314002, W68314003, W68314004, W68314005, W68315001, W68315002, W68315003, W68315004, W68315005, W68316001, W68316002, W68316003, W68316004, W68316005, W68317001, W68317002, W68317003, W68317004, W68317005
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683280337275
Country: US	FDA, National Drug Code	Identifier(s): 0006-0267, 0006-3801
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/7.3/0534, 32/7.3/0535, 32/7.3/0536, 32/7.3/0537